InvestSMART

Monash IVF Group Limited (ASX: MVF) - ETF Exposure

Current share price for MVF : $0.575 0.18 (23.84%)+

Monash IVF Group Limited (MVF) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It provides human fertility services and is one of the providers of Assisted Reproductive Services (ARS) which is the component of fertility care in Australia and South East Asia. ARS encompass a range of techniques used to assist patients experiencing infertility to achieve a clinical pregnancy including reproductive genetic services. In addition, the Group is a provider of women's imaging services.

MVF General Information +

ASX Code MVF
Website N/A
Industry/Sector Health Care Facilities
Market Cap ($M) 224
MVF Share Price $0.575
Day High $0.650
Day Low $0.570
Last Close $0.755
MVF Share Price Movement $0.18 ( 23.84% )
Prices as at 16:40, 20 Nov 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to MVF

Monash IVF Group Limited (MVF) is held across 7 ETFs spanning strategies that include health care facilities exposure . Its weighting in those funds means performance can have an outsized influence - when MVF moves, funds like DAVA, DACE and PGA1 that hold it can move with it.

For more concentrated exposure, ETFs such as DAVA (Dimensional Australian Value Trust - Active ETF) allocate about 0% to MVF , while the average exposure across all 7 ETFs that hold it is around 0% .

Top ETF holdings

Last updated: ETF data and holdings as at 21 November 2026

Own MVF directly or through an ETF?

How does holding Monash IVF Group Limited (MVF) shares directly compare to ETFs that include it?

MVF Direct
DAVA
ASX
DACE
ASX
PGA1
ASX
Holdings 1 company 193 holdings 510 holdings 2,947 holdings
MVF Weight 100% 0% 0% 0%
Diversification Single Stock Broad Broad Broad
Annual Cost Brokerage only 0.34% p.a. 0.28% p.a. 0.85% p.a.
Approx. Yield 3.5% 6.92% 3.31% -
Star Ratings - starstarstarstarstar starstarstarstar starstar

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not MVF's direct yield. Annual cost uses each ETF's MER.

MVF Exposure on $10,000 investment

How a $10,000 investment in Monash IVF Group Limited (MVF) one week ago compares with ETFs that hold it.

Security Investment type Current price 7-day price movement Dollar change Value today
Monash IVF Group Limited (MVF) Direct share $0.575 -23.33% -$2,333 $7,667
Dimensional Australian Value Trust - Active ETF (DAVA) Equity - Australia Strategy $30.080 -6.06% -$606 $9,394
Dimensional Australian Core Equity (Managed Fund) (DACE) Equity - Australia Strategy $17.820 -6.36% -$636 $9,364
Plato Global Alpha Fund Complex ETF (PGA1) Equity - Global Strategy $14.720 -4.23% -$423 $9,577

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Monash IVF Group Limited (MVF) ETFs

7 ETFs hold Monash IVF Group Limited (MVF).

ETF MVF Weight MER Yield
Dimensional Australian Value Trust - Active ETF (DAVA) 0% 0.34% 6.92%
Dimensional Australian Core Equity (Managed Fund) (DACE) 0% 0.28% 3.31%
Plato Global Alpha Fund Complex ETF (PGA1) 0% 0.85% -

View all 7 ETFs

Monash IVF Group Limited (MVF) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
HFResult 1.3¢ 100% 3 Sep 2026 15 Oct 2026 - - -
Result 1.2¢ 100% 4 Mar 2026 10 Apr 2026 - - -
Result 2.6¢ 100% 6 Mar 2025 11 Apr 2025 - - -

See all dividends from Monash IVF Group Limited (MVF) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Monash IVF Group Limited (MVF) price-sensitive announcements

MVF - FY27 Trading Update
Monash IVF Group Limited’s FY27 Trading Update for the period from 1 July 2026 to 20 Novem
Monash IVF Group Limited (MVF)
20 Nov 2026 | 9:23 AM
MVF - MVF FY26 Investor Presentation
Monash IVF Group Limited’s FY26 Investor Presentation outlines a year of two halves, with
Monash IVF Group Limited (MVF)
31 Aug 2026 | 8:28 AM
MVF - MVF FY26 Results Announcement
Monash IVF Group Limited’s FY26 results announcement reported revenue of $269.5 million, U
Monash IVF Group Limited (MVF)
31 Aug 2026 | 8:16 AM
MVF - MVF FY26 Appendix 4E and Financial Report
Monash IVF Group Limited’s FY26 Appendix 4E and Financial Report for the year ended 30 Jun
Monash IVF Group Limited (MVF)
31 Aug 2026 | 8:14 AM

Monash IVF Group Limited (MVF) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Monash IVF Group Limited (MVF)
ORDINARY FULLY PAID
Health Care $224 FY27 Trading Update 20 Nov 2026 9:23AM $0.755 $0.575 fallen by 23.84%
Monash IVF Group Limited (MVF)
ORDINARY FULLY PAID
Health Care $224 Appendix 3Y 9 Nov 2026 6:29PM $0.740 $0.575 fallen by 22.30%
Monash IVF Group Limited (MVF)
ORDINARY FULLY PAID
Health Care $224 Appendix 3X 9 Nov 2026 6:28PM $0.740 $0.575 fallen by 22.30%
Monash IVF Group Limited (MVF)
ORDINARY FULLY PAID
Health Care $224 Appendix 3Z 30 Oct 2026 4:31PM $0.720 $0.575 fallen by 20.14%
Monash IVF Group Limited (MVF)
ORDINARY FULLY PAID
Health Care $224 Appendix 3Z 30 Oct 2026 4:31PM $0.720 $0.575 fallen by 20.14%
Monash IVF Group Limited (MVF)
ORDINARY FULLY PAID
Health Care $224 Appendix 3Z 26 Oct 2026 9:09AM $0.715 $0.575 fallen by 19.58%

MVF Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2028F C2 $5.30 14.10% 11.00 3.10 5.30% 0.0%
2027F C2 $4.60 35.70% 12.50 2.40 4.20% 0.0%
2026A $14.13 $3.40 -47.50% 21.30 2.50 3.50% 100.0%

MVF Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2026 A 2027 F 2028 F 2026 A 2027 F 2028 F 2026 A 2027 F 2028 F
Monash IVF Group Limited (MVF) $294M -0.4752 0.3569 0.1413 22.2714 16.4130 14.3810 3.31% 3.18% 4.04%
Regis Healthcare Limited (REG) $1,443M 0.2575 -0.2366 0.1588 21.4189 28.0588 24.2132 3.86% 3.21% 3.71%
Ramsay Health Care Limited (RHC) $12,559M -0.0201 0.1363 0.1419 35.3426 31.1021 27.2377 1.67% 1.89% 2.17%

MVF Directors

Name Position Start Date
Ms Zita Peach Non-Executive Director 12 Oct 2016
Dr Dwayne Crombie Non-Executive Director 24 Nov 2025
Ms Catherine (Cathy) Ann Aston Non-Executive Director 26 Feb 2024
Ms Victoria Atkinson Non-Executive Director 5 Jan 2026
Ms Catherine Jane West Non-Executive Director, Non-Executive Chairman 8 Sep 2020

Monash IVF Group Limited (MVF) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
7 Oct 2026 ASTON, Catherine (Cathy) Buy Direct Shares 33,000 $0.745 $24,585.000
29 Dec 2025 ASTON, Catherine (Cathy) Sell Indirect Shares 75,000 $0.719 $53,928.710
16 Sep 2024 ASTON, Catherine (Cathy) Buy Direct Shares 2,000 $1.211 $2,422.597

See all changes in directors' interest & trades for Monash IVF Group Limited (MVF) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

MVF Management

Name Position
Rebecca Dean Company Secretary,General Counsel

MVF Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Monash IVF Group Limited (MVF). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
76,367,969 (19.60%) Washington H. Soul Pattinson and Company Limited
24,375,402 (6.26%) Argo Investments Limited
19,626,468 (5.04%) Unisuper Limited

MVF Calendar of Events

Date Event
22 October 2027 Report (Annual)
22 October 2027 Report (Prelim)
30 August 2027 Report (Annual)
30 August 2027 Report (Prelim)
25 February 2027 Report (Interim)
26 November 2026 AGM

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.